Mr. Speaker, I thank the member for Halifax for her very passionate response to an equally passionate and powerful presentation by the member for Oakville.
In the member for Oakville's speech, he referred to the fact that GlaxoSmithKline, as just one example, paid a fine of $3 billion, having made $26 billion in the period of time at issue. However, what I see in this bill before us, if I understand it properly, is that the maximum is $5 million and imprisonment, I am pleased to see. As the member for Oakville pointed out, no big pharma rep has ever been to jail.
As you talk about the amendments you would be seeking in this legislation, would you support a larger fine beyond the $5 million that is currently in the bill, in order to address the huge discrepancy that the member for Oakville brought to our attention?